Treat Raises €3M Pre-seed
Treat raises €3 million in a pre-seed round led by byFounders to scale its AI-native private healthcare platform for employers.
Treat Raises €3M Pre-seed
Treat, a Helsinki-based HealthTech startup that leverages artificial intelligence to streamline private healthcare, has raised €3 million in a pre-seed funding round.
Investors
The round was led by byFounders, an early-stage venture capital firm, with participation from Illusian, the investment vehicle of Supercell founder Ilkka Paananen.
Treat Use of Funds
Treat intends to use the capital to support its commercial expansion and continue the development of its product, particularly as it scales its employer-facing healthcare offering across Finland and international markets.
About Treat
Founded in 2026 by Sami Marttinen, Antti Mauno, and Onni Wahlberg, Treat is an AI-native platform designed to connect patients with licensed physicians. The service utilizes an AI-powered intake tool to structure patient information into a brief, which is then reviewed by a doctor to ensure clinical decisions are made by humans rather than algorithms. The platform aims to resolve healthcare concerns efficiently, focusing on an incentive model that prioritizes patient resolution over the volume of appointments.
Funding Details
Company Website: https://treat.health/
Company: Treat
Raised: €3M
Round: Pre-seed
Funding Date: November 17, 2026
Lead Investor: byFounders
Additional Investors: Illusian
Software Category: HealthTech